Labcorp Holdings Inc.
- LH
- NYSE
- Medical - Diagnostics & Research
- Diagnostic Lab Services
- Clinical Testing Services
$317.95
Today −2.19%Quote Oct 16, 2026, 08:00 PM UTC
−1.48%over the last month
Max drawdown −5.8%From 1-month high −2.2%3 months +13.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$25.79B
Quote Oct 16
Next earnings
Oct 28
Expected, not confirmed
Analyst target
$346.57
+9.0% from here
Floor
$311.75
1.9% below price
Where the price sits
35 analysts
Analyst range, low to high
$306.00$380.00
- Price $317.95
- Resistance $318.58
- Consensus $346.57
The price is just above its floor and right under resistance. Analysts' average target sits about 9% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $3.74B
- LabCorp Diagnostics$2.90B77.6%
- Biopharma Laboratory Services$836.2M22.4%
Industry
Medical - Diagnostics & Research
Employees
71,000